Cite
HARVARD Citation
Nakagawa, T. et al. (n.d.). Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway‐induced resistance to vascular endothelial growth factor receptor inhibitor. Cancer science. 105 (6), pp. 723-730. [Online].